![Andrew Keck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historial de carrera de Andrew Keck
Antiguos cargos conocidos de Andrew Keck.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
TYME TECHNOLOGIES, INC. | Comptroller/Controller/Auditor | 22/11/2011 | 26/04/2013 |
Director/Miembro de la Junta | 22/11/2011 | 26/04/2013 | |
Director Ejecutivo | 22/11/2011 | 26/04/2013 | |
Director Financiero/CFO | 22/11/2011 | 26/04/2013 | |
Fundador | 22/11/2011 | 26/04/2013 | |
Presidente | 22/11/2011 | 26/04/2013 | |
Secretario Corporativo | 22/11/2011 | 26/04/2013 | |
Treasurer | 22/11/2011 | 26/04/2013 |
Estadísticas
Internacional
Estados Unidos | 2 |
Operativa
Comptroller/Controller/Auditor | 1 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Tyme Technologies, Inc.
![]() Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Keck
- Experiencia